HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

R.P. Scherer

This article was originally published in The Rose Sheet

Executive Summary

Manufacturer of the TruScent gelatin capsule fragrance sampling system announces acquisition by wholesale distributor Cardinal Health May 18. Cardinal will pay about $2.4 bil. for the world's largest gelatin capsule manufacturer, with Scherer shareholders receiving .95 Cardinal common shares for each Scherer share. Cardinal will also assume about $159 mil. in long-term Scherer debt. R.P. Scherer will be run as a separate operating facility under current management, which is headed by Chairman and CEO Alex Erdeljan and President and Chief Operating Officer George Fotiades. The size of the transaction may indicate that Dublin, Ohio-based Cardinal does not foresee a successful completion of its proposed merger with Bergen Brunswig, which the Federal Trade Commission is attempting to block ("The Rose Sheet" March 23, In Brief). Troy, Mich.-based R.P. Scherer also holds an exclusive licensing agreement with Advanced Polymer Systems to use APS' Microsponge technology in its unit-dose softgel capsules...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005445

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel